Two Sigma Advisers’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,900
| Closed | -$107K | – | 2491 |
|
|
2025
Q1 | $107K | Buy |
53,900
+10,700
| +25% | +$21.3K | ﹤0.01% | 2232 |
|
|
2024
Q4 | $126K | Sell |
43,200
-76,700
| -64% | -$224K | ﹤0.01% | 2192 |
|
|
2024
Q3 | $464K | Sell |
119,900
-56,600
| -32% | -$219K | ﹤0.01% | 1741 |
|
|
2024
Q2 | $907K | Buy |
176,500
+12,500
| +8% | +$64.3K | ﹤0.01% | 1595 |
|
|
2024
Q1 | $1.15M | Buy |
164,000
+118,000
| +257% | +$826K | ﹤0.01% | 1518 |
|
|
2023
Q4 | $408K | Buy |
+46,000
| New | +$408K | ﹤0.01% | 1997 |
|